Genethon and Hansa Biopharma report GNT-018-IDES trial data showing imlifidase [...]

Kairos Pharma, Ltd. will present positive safety and early efficacy [...]

Skye Bioscience has reported topline results from its Phase 2a [...]

Amorphical, developer of nano-amorphous mineral-based pharmacologic agents, has announced positive [...]

A gene therapy developed by uniQure appears to slow progression [...]

CellProthera has published peer-reviewed results from its phase 1/2b Excellent [...]

Peer-reviewed trial results demonstrate robust bacterial reduction without resistance in [...]

Partnership further validates Ethris’ novel technology platform based on stabilized [...]

AstriVax Therapeutics has initiated a phase 1 clinical trial of [...]

Poolbeg Pharma has been granted Orphan Drug Designation (ODD) by [...]